FX006
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for FX006, covering 2017-12-21 to 2024-01-02. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis [Phase 2]